Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Immune-Related Adverse Events and Clinical Outcomes in Advanced Urothelial Cancer Patients Treated With Immune Checkpoint Inhibitors

The Oncologist(2023)10.1093/oncolo/oyad154Source: DataRank Database

Immune-Related Adverse Events and Clinical Outcomes in Advanced Urothelial Cancer Patients Treated With Immune Checkpoint Inhibitors is a research paper published in The Oncologist (2023). On theSindex it has a DataRank of 0. It has been cited 12 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access12 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)OA: goldTopics (20)IDs (PubMed, PMC)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (18)

Julie M. Shabto ORCID,Subir Goyal ORCID,Yuan Liu ORCID,Dylan J. Martini ORCID,Bassel Nazha ORCID

Live enrichment

PubMed:37285524 PMC:PMC10712712

NCI

Grant: P30CA138292

National Institutes of Health

Grant: 5P30CA138292-11

Winship Cancer Institute Cancer Center Support Grant

NIH HHS

National Institutes of Health

goldLicense: CC BY NC

publisherhttps://academic.oup.com/oncolo/article-pdf/28/12/1072/54874732/oyad154.pdf

Europe_PMChttps://europepmc.org/articles/PMC10712712

Europe_PMChttps://europepmc.org/articles/PMC10712712?pdf=render

https://doi.org/10.1093/oncolo/oyad154

https://pubmed.ncbi.nlm.nih.gov/37285524

Fields of Study

03 medical and health sciences0302 clinical medicine

MeSH Terms

HumansCarcinoma, Transitional CellRetrospective StudiesPatientsUrinary Bladder NeoplasmsImmune Checkpoint Inhibitors

Keywords

Bladder cancerOutcomesUrothelial CancerImmune-related Adverse EventsCheckpoint InhibitorGenitourinary CancerCarcinoma, Transitional CellUrinary Bladder NeoplasmsPatientsHumansImmune Checkpoint InhibitorsRetrospective Studies